August 4, 2022 | Issue #12

Good evening.

It's a special day over here at Spannr as we have some exciting news to announce.

To add, we've also updated our website allowing for easier navigation to our archive, syndicate, and latest product. 

Simply

visit our website

to see all that's new, or just continue reading below...

In this week's newsletter:

📈 Tracking longevity stocks just got

a lot

easier

📌 Spannr's 2022 Company Report

📚 The latest good-reads circling around the web

Introducing The Spannr Longevity Stock Index

The longevity industry is on track to be worth trillions of dollars in the coming years. But what if you wanted to invest? Do you know where and how to spot the opportunities?If you’ve been looking for these answers, don’t fret – we’re here to help.That’s why today, we’re excited to announce the launch of the Spannr Longevity Stock Index.In our latest post, we discuss what the index entails, why we took this project on, and what users can do with this new data at their fingertips. Continue Reading >>

Kickstart Longevity Investing With Our Latest Report

In conjunction with the launch of Spannr's Longevity Stock Index, today we released our inaugural Company Report intended to guide readers through the complicated world of longevity biotechnology investing.Inside the 50-page report, you will find a variety of publicly-traded companies that investors can gain exposure to today.To help paint a clearer picture of today’s public market environment, we have also provided company descriptions, core focuses, and stock information such as market capitalization, ticker symbols, charts, and exchange data.Furthermore, we have included information on the top private companies in the space. That’s because, as many of us know, the public market isn’t the only place one can deploy capital.To download the PDF, just click here. The link will be sent to your inbox shortly after.

Note: There are dozens of private companies that are not featured in this report.If you are an accredited investor, you can join Spannr Ventures to participate in investment opportunities that may include companies in this report or with companies that are still in stealth.

• A ‘Reversible’ Form of Death? Scientists Revive Cells in Dead Pigs’ Organs (New York Times)

• Dr. Matt Kaeberlein Discusses the Dog Aging Project and Longevity On The Tim Ferriss Show (The Tim Ferriss Show)

• This startup wants to copy you into an embryo for organ harvesting (MIT Technology Review)

• Conflicts of interest for members of the U.S. 2020 Dietary Guidelines Advisory Committee (PubMed)

• DeepMind has predicted the structure of almost every protein known to science (MIT Technology Review)

• Should We Consider Aging a Disease? (Raiany Romanni; Quillette)